Can paxlovid beat long COVID? major trial reveals results
NCT ID NCT05965726
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the antiviral drug Paxlovid can help people with Long COVID by clearing leftover virus or calming an overactive immune system. Nearly 1,000 adults took either Paxlovid or a placebo for different lengths of time. Researchers tracked improvements in thinking, dizziness, and energy levels over 90 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
All sites listed under NCT05595369
Durham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Could exercise retrain the heart in long COVID?
- Can brain games and gentle currents lift long COVID brain fog?
- Can brain training zap long COVID brain fog?
- Ear device zaps vagus nerve in bid to quiet long COVID fatigue and brain fog
- Smartphone therapy could ease long COVID's mental toll